Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis

Journal of Neurology
Isabell CordtsKristl G Claeys

Abstract

In autoimmune myasthenia gravis (MG), the identification of antibodies and characterization of serological subgroups is of great importance for diagnosis and management of the disease. Our aims were to study the frequency of antibodies against lipoprotein-related protein 4 (LRP4), agrin, and titin using the most recent techniques, and to characterize corresponding clinical features and autoimmune diseases (AID) in 100 MG-patients. The antibody frequencies in the 55 AChR-antibody positive patients were 7% LRP4, 5% agrin, 53% titin, and in the 45 AChR-antibody negative patients 2% MuSK, 2% LRP4, 2% agrin, and 27% titin. LRP4-MG presented late-onset age, mild symptoms, good therapeutic response, and no thymic changes. Agrin-MG showed early onset age, mild-to-severe symptoms, and moderate treatment response. The phenotype of titin-MG depended on AChR-antibodies: AChR-antibody negative patients presented with mostly mild limb muscle weakness, whereas AChR-antibody positive patients showed more frequently severe symptoms, including myasthenic crisis, bulbar predominance, and thymoma. Additional AID were detected in 32% of MG-patients, most frequently Hashimoto's thyroiditis (21%). Based on our data, we recommend the detection of LRP4...Continue Reading

References

Sep 1, 1982·Acta Endocrinologica·W R KiesslingH Schleusener
May 1, 1996·Neuromuscular Disorders : NMD·A EvoliP Tonali
Jul 15, 2000·Journal of Neurology·F RomiN E Gilhus
Jun 25, 2003·Brain : a Journal of Neurology·Amelia EvoliEmanuela Bartoccioni
Oct 17, 2003·The New England Journal of Medicine·Melissa R ArbuckleJohn B Harley
Oct 19, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M KanazawaM Nishizawa
Jun 3, 2008·Brain : a Journal of Neurology·Maria Isabel LeiteAngela Vincent
Jun 24, 2008·Annals of the New York Academy of Sciences·Johan A Aarli
Oct 14, 2008·Cell·Natalie KimSteven J Burden
Apr 21, 2009·Lancet Neurology·Matthew N Meriggioli, Donald B Sanders
May 19, 2009·Practical Neurology·Niraj MistryMartin R Turner
Jul 24, 2010·Current Opinion in Neurology·Maria Elena Farrugia, Angela Vincent
Dec 15, 2010·The International Journal of Neuroscience·Zhi-Feng MaoMaree L Hackett
Mar 10, 2011·Annals of Neurology·Osamu HiguchiYuji Yamanashi
Aug 5, 2011·Journal of Neurology·Alexandra PevznerStephan Kröger
Feb 4, 2012·Genes & Development·Yinong ZongRongsheng Jin
Mar 6, 2012·Autoimmunity Reviews·Scott M Hayter, Matthew C Cook
Jun 26, 2012·Acta Neurologica Scandinavica·Y-L ChenH-C Chiu
Jan 3, 2013·Annals of the New York Academy of Sciences·Judith CossinsDavid Beeson
Oct 12, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·P DevicL Schaeffer
Nov 10, 2013·The Journal of Clinical Investigation·Chengyong ShenLin Mei
Mar 19, 2014·PloS One·Bin ZhangLin Mei
May 6, 2014·Neurology·Christiane GasperiStephan Kröger
Jun 21, 2014·Acta Neurologica Scandinavica·P SzczudlikA Kostera-Pruszczyk
Sep 7, 2014·Autoimmunity Reviews·Eduard GallardoIsabel Illa
Oct 31, 2014·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·N E GilhusJ F Owe
May 31, 2015·Journal of Neuroimmunology·A I TsonisS J Tzartos
Jun 13, 2015·Scientific Reports·Guang ZhaoJianming Jiang
Nov 1, 2015·Journal of the American Academy of Dermatology·Liza GillIltefat Hamzavi
Mar 6, 2016·Journal of Neuroimmunology·C StergiouS J Tzartos

❮ Previous
Next ❯

Citations

Nov 16, 2017·Médecine sciences : M/S·Oana CatarAleksandra Nadaj-Pakleza
Jun 27, 2018·Neurodegenerative Disease Management·Pedro J Modrego
Aug 30, 2018·Current Opinion in Neurology·Renato MantegazzaPaola Cavalcante
Feb 16, 2019·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Anne HeikkinenTaina Pihlajaniemi
Jan 30, 2019·Acta Neurologica Scandinavica·Madhu NagappaArun B Taly
Aug 22, 2017·Expert Opinion on Therapeutic Targets·Kinji OhnoMikako Ito
Jan 30, 2018·Annals of the New York Academy of Sciences·Angela VincentDavid Beeson
Apr 18, 2018·Neurology·Karen HewettUNKNOWN BEL115123 Study Group
May 3, 2019·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M LiF Gao
Mar 3, 2020·Frontiers in Immunology·Konstantinos Lazaridis, Socrates J Tzartos
Dec 10, 2020·Muscle & Nerve·Jeffrey T GuptillJohn S Yi
Dec 18, 2020·Frontiers in Neurology·Konstantinos Lazaridis, Socrates J Tzartos
May 8, 2021·Journal of Neuroimmunology·Kathrin DopplerClaudia Sommer
May 11, 2021·Expert Review of Molecular Diagnostics·Matteo GastaldiDiego Franciotta
Aug 18, 2021·Journal of Medical Genetics·Apostolia TopaloudiPeristera Paschou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

© 2022 Meta ULC. All rights reserved